Heat-stable ritonavir approved, ending treatment stranglehold for people living with HIV/AIDSread more
Make It Happen Campaign Update: UNITAID Board still discussing finer details of the Patent Pool Entity read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
U.S. health care legislation could limit access read more
MSF responds to World Health Organization’s new HIV treatment guidelines read more
MSF sends letter to EU Ministers of Health regarding antibiotic resistance read more
Every day, Médecins Sans Frontières (MSF) is confronted with the lack of access to adequate or affordable medical tools in the field. We face two major challenges – the high cost of existing medicines on the one hand, and the absence of appropriate or effective treatments for many of the diseases affecting our patients on the other.
This new book by Ellen ‘t Hoen, former Director of Policy Advocacy for the MSF Access Campaign, explains why these twin challenges are in fact two sides of the same coin. More importantly perhaps, it also analyses the latest mechanisms and policy changes that may help change the broken system of medical innovation and access to medicines today.
In particular, the book highlights recent alternative mechanisms to encourage medical R&D in a way that also ensures access to the developed product – by separating the cost of research and development from the price of diagnostics, medicines, and vaccines.
As such, MSF wholeheartedly welcomes the publication, in the hope that it may both spur efforts, such as a patent pool, to speed up access to newer medicines, and boost initiatives that make use of alternative financing mechanisms in order to develop new, more appropriate treatments that respond to medical needs.
This book is available under a Creative Commons License for free download or online reading.
To read or download the book click here
To buy the book click here

People Living with HIV/AIDS: India must not sacrifice us in trade agreement with Europe
Indian Court Gives Boost to Access to Medicines As Latest Appeal By Bayer is Rejected
UNITAID Patent Pool: Innovative Initiative Designed to Boost Access to Medicines is Adopted
MSF Clinical Officer Olesi Ellemani Pasulani's reflections on AIDS treatment in Malawi
Living with MDR TB: 'Expert Client' Nonkululeko Mamba's Story
MDR TB Treatment in Cambodia: A Catalyst for Change